The Chicago Entrepreneur

J&J to acquire V-Wave for up to $1.7 billion in play for heart-failure device

The device, which can be inserted through a minimally invasive catheter-based procedure, received FDA Breakthrough Device Designation in 2019 and has the potential to become the first device of its kind to market, Johnson & Johnson said.

Previous post AMD’s stock looks to extend gains as its splashy AI deal draws cheers
Next post Brett explodes as Bitcoin Dogs eyes top crypto exchange listings